Gen-Probe's Q1 Revenues up 7 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe today said that revenues for the first quarter rose 7 percent year over year as blood-screening revenues increased 12 percent.

The San Diego-based molecular diagnostics firm also announced a deal to be acquired by Hologic for $82.75 per share in cash for a total deal value of $3.7 billion.

Gen-Probe's revenues totaled $153.4 million, up from $143 million a year ago, and beating Wall Street estimates of $150.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.